Business Description
Bliss GVS Pharma Ltd
NAICS : 325412
ISIN : INE416D01022
Compare
Compare
Traded in other countries / regions
506197.India IPO Date
1991-01-07Description
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from exports.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.48 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | 0.69 | |||||
| Interest Coverage | 16.39 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5 | |||||
| Beneish M-Score | -2.97 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.2 | |||||
| 3-Year EBITDA Growth Rate | 5.1 | |||||
| 3-Year EPS without NRI Growth Rate | 13.6 | |||||
| 3-Year FCF Growth Rate | 31 | |||||
| 3-Year Book Growth Rate | 5.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 94.74 | |||||
| 9-Day RSI | 84.47 | |||||
| 14-Day RSI | 75.65 | |||||
| 6-1 Month Momentum % | 13.03 | |||||
| 12-1 Month Momentum % | -18.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.42 | |||||
| Quick Ratio | 3.74 | |||||
| Cash Ratio | 1.21 | |||||
| Days Inventory | 114.65 | |||||
| Days Sales Outstanding | 185.1 | |||||
| Days Payable | 74.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.35 | |||||
| Dividend Payout Ratio | 0.08 | |||||
| Forward Dividend Yield % | 0.35 | |||||
| 5-Year Yield-on-Cost % | 0.16 | |||||
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | 0.68 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.99 | |||||
| Operating Margin % | 16.43 | |||||
| Net Margin % | 7.49 | |||||
| FCF Margin % | 15.6 | |||||
| ROE % | 6.15 | |||||
| ROA % | 4.84 | |||||
| ROIC % | 9.68 | |||||
| ROC (Joel Greenblatt) % | 12.65 | |||||
| ROCE % | 10.4 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 26.92 | |||||
| PE Ratio without NRI | 26.92 | |||||
| Shiller PE Ratio | 12.81 | |||||
| Price-to-Owner-Earnings | 20.06 | |||||
| PS Ratio | 2.06 | |||||
| PB Ratio | 1.68 | |||||
| Price-to-Tangible-Book | 1.68 | |||||
| Price-to-Free-Cash-Flow | 13.65 | |||||
| Price-to-Operating-Cash-Flow | 11.13 | |||||
| EV-to-EBIT | 14.06 | |||||
| EV-to-EBITDA | 11.23 | |||||
| EV-to-Revenue | 1.93 | |||||
| EV-to-FCF | 9.83 | |||||
| Price-to-Projected-FCF | 1.71 | |||||
| Price-to-Graham-Number | 1.42 | |||||
| Price-to-Net-Current-Asset-Value | 2.9 | |||||
| Earnings Yield (Greenblatt) % | 7.11 | |||||
| FCF Yield % | 7.37 | |||||
| Forward Rate of Return (Yacktman) % | -4.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bliss GVS Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 7,958.315 | ||
| EPS (TTM) (₹) | 5.94 | ||
| Beta | 1.44 | ||
| Volatility % | 79.09 | ||
| 14-Day RSI | 75.65 | ||
| 14-Day ATR (₹) | 8.286767 | ||
| 20-Day SMA (₹) | 127.52 | ||
| 12-1 Month Momentum % | -18.41 | ||
| 52-Week Range (₹) | 92.25 - 165 | ||
| Shares Outstanding (Mil) | 105.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bliss GVS Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bliss GVS Pharma Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bliss GVS Pharma Ltd Frequently Asked Questions
What is Bliss GVS Pharma Ltd(BOM:506197)'s stock price today?
The current price of BOM:506197 is ₹159.90. The 52 week high of BOM:506197 is ₹165.00 and 52 week low is ₹92.25.
When is next earnings date of Bliss GVS Pharma Ltd(BOM:506197)?
The next earnings date of Bliss GVS Pharma Ltd(BOM:506197) is .
Does Bliss GVS Pharma Ltd(BOM:506197) pay dividends? If so, how much?
The Dividend Yield %  of Bliss GVS Pharma Ltd(BOM:506197) is 0.35% (As of Today), Highest Dividend Payout Ratio of Bliss GVS Pharma Ltd(BOM:506197) was 0.21. The lowest was 0.05. And the median was 0.08. The  Forward Dividend Yield % of Bliss GVS Pharma Ltd(BOM:506197) is 0.35%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers